We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

38 hedge funds and large institutions have $9.37M invested in Actinium Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

284% more call options, than puts

Call options by funds: $5M | Put options by funds: $1.3M

100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 6

0.7% less ownership

Funds ownership: 8.98% → 8.28% (-0.7%)

10% less funds holding

Funds holding: 42 → 38 (-4)

18% less capital invested

Capital invested by funds: $11.5M → $9.37M (-$2.12M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
38
Holders Change
-4
Holders Change %
-9.52%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
6
Closed
9
Calls
$5M
Puts
$1.3M
Net Calls
+$3.7M
Net Calls Change
+$3.53M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$187K
2
Citadel Advisors
Citadel Advisors
Florida
+$130K
3
Simplex Trading
Simplex Trading
Illinois
+$102K
4
William Blair & Company
William Blair & Company
Illinois
+$72.1K
5
Group One Trading
Group One Trading
Illinois
+$60.8K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$386K
2
GCP
GSA Capital Partners
United Kingdom
-$341K
3
ACM
ACT Capital Management
Pennsylvania
-$163K
4
DLG
Daniel L. Goodwin
-$60K
5
Morgan Stanley
Morgan Stanley
New York
-$53.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$6K +$700 +133 +15%
CAPTRUST Financial Advisors
27
CAPTRUST Financial Advisors
North Carolina
$6K +$874 +166 +17%
CG
28
Cutler Group
California
$5K +$5.27K +1,000 New
National Bank of Canada
29
National Bank of Canada
Quebec, Canada
$4K – – –
HFM
30
Hartford Financial Management
Connecticut
$3K – – –
BCV
31
Banque Cantonale Vaudoise
Switzerland
$2K – – –
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$2K +$2.11K +400 +6,667%
GFPC
33
Global Financial Private Client
Florida
$1.36K – – –
Northwestern Mutual Wealth Management
34
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
TWA
35
TCI Wealth Advisors
Arizona
$1K – – –
SM
36
Sabby Management
Florida
– -$386K -73,366 Closed
GCP
37
GSA Capital Partners
United Kingdom
– -$341K -56,673 Closed
DLG
38
Daniel L. Goodwin
– -$60K -10,000 Closed
Bank Julius Baer & Co
39
Bank Julius Baer & Co
Switzerland
– -$18K -3,028 Closed
SWM
40
Spire Wealth Management
Virginia
– -$11K -1,800 Closed
GWS
41
Glassman Wealth Services
Virginia
– +$5 +1 New
1
2

ATNM Hedge Fund Activity: Q1 2022 in Review

38 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q1 2022, worth a combined $9.37M — down 18% from $11.5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ATNM and 5 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 12 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $187K. The largest seller was Sabby Management, exiting entirely with an estimated $386K sold.

  • 38 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q1 2022, down from 42 in Q4 2021.
  • Funds reported $9.37M of Actinium Pharmaceuticals stock for Q1 2022, down 18% quarter-over-quarter.
  • 5 funds opened new Actinium Pharmaceuticals positions in Q1 2022 and 9 closed out, a net change of -4 holders.
  • The largest Actinium Pharmaceuticals buyer in Q1 2022 was Susquehanna International Group, an estimated $187K added.
  • The largest Actinium Pharmaceuticals seller in Q1 2022 was Sabby Management, an estimated $386K sold.

Based on aggregated 13F filings for Q1 2022.